Thomas Leo Lenz, PharmD

Department

Family and Community Medicine

Position

Professor

Books

• Lenz Thomas L., Lifestyle modifications in pharmacotherapy 2012
• Lenz Thomas L., Lifestyle modifications in pharmacotherapy 2008
• Lenz Thomas L., Lifestyle modifications in pharmacotherapy 2007

Articles

• U.S. Pharmacist
  Lenz Thomas L., DeSimone Edward M., Pomeroy Jamie M., Implementing lifestyle medicine in hypertensive patients
  36, p. 44 - 50 2011
• Pharmacy Times
  Lenz Thomas L., Monaghan Michael S., Chock Alan W.Y., Stading Julie A., Controlling diabetes
  76 2010
• U.S. Pharmacist
  Lenz Thomas L., Petersen Katie, Monaghan Michael S., Counseling patients about lifestyle modification
  33, p. 38 - 45 2008

Publications

• American Journal of Lifestyle Medicine
  Merlo Gia, Tollefson Michelle, Dacey Marie, Lenz Thomas, Luchsinger Mary, Muscato Dennis, Frates Elizabeth Pegg, Laying an Early Foundation
  14:5, p. 474 - 482 2020
• American Journal of Lifestyle Medicine
  White Nicole D., Bautista Vicki, Lenz Thomas, Cosimano Amy, Using the SMART-EST Goals in Lifestyle Medicine Prescription
  14:3, p. 271 - 273 2020
• American Health and Drug Benefits
  White Nicole D., Lenz Thomas L., Skrabal Maryann Z., Skradski Jessica J., Lipari Louis, Long-term outcomes of a cardiovascular and diabetes risk- reduction program initiated by a self-insured employer
  11:4, p. 177 - 181 2018
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Drugs that Negatively Affect Sleep
  8:6, p. 383 - 385 2014
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Documenting Lifestyle Medicine Activities
  8:4, p. 242 - 243 2014
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Developing Lifestyle Medicine Tools from Psychological Theories
  8:1, p. 28 - 30 2014
• Pharmacotherapy
  Ling Hua, Lenz Thomas L., Burns Tammy L., Hilleman Daniel E., Reducing the Risk of Obesity: Defining the Role of Weight Loss Drugs
  33:12, p. 1308 - 1321 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Pharmacists Improving Health at the Worksite
  7:6, p. 382 - 384 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Prevalence of Medication use in Children for Cardiometabolic Risk Reduction
  7:5, p. 310 - 312 2013
• Psychology Research and Behavior Management
  White Nicole D., Lenz Thomas L., Smith Katherine M., Tool guide for lifestyle behavior change in a cardiovascular risk reduction program
  6, p. 55 - 63 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Drug-Alcohol Interactions
  7:4, p. 250 - 252 2013
• American Journal of Lifestyle Medicine
  White N. D., Lenz Thomas L., Drug-Induced Photosensitivity and the Major Culprits
  7:3, p. 189 - 191 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Seyer Matthew R., A Pharmacological/Physiological Comparison of Metformin and Exercise
  7:2, p. 118 - 120 2013
• ISRN preventive medicine
  Lenz Thomas L., Gillespie Nicole D., Skradski Jessica J., Viereck Laura K., Packard Kathleen A., Monaghan Michael S., Development of a Composite Lifestyle Index and Its Relationship to Quality of Life Improvement: The CLI Pilot Study
  2013, p. 1 - 7 2013
• The Internet journal of allied health sciences and practice
  Lenz Thomas, Gillespie Nicole, Monaghan Michael, Finding Employees with Undiagnosed Diabetes
  11:2 2013
• Journal of the American Pharmacists Association
  White Nicole D., Skrabal Maryann Z., Faulkner Michele A., Skradski Jessica J., Southard Leslie A., Popken Derek E., Lenz Thomas L., Comparison of cardiovascular risk calculation tools in pharmacy practice
  53:4, p. 408 - 413 2013
• Journal of Interprofessional Care
  Lenz Thomas L., Pagenkemper Joni J., Moore Geri A., Jorgensen Diane, Skradski Jessica J., Gillespie Nicole D., Skrabal Maryann Z., Faulkner Michele A., Ferguson Liz A., Using employee experts to offer an interprofessional diabetes risk reduction program to fellow employees
  27:2, p. 197 - 199 2013
• Lenz Thomas L., Employee health 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Larson Jessica C., Medication use for Hypercholesterolemia in the Pediatric Population
  6:6, p. 455 - 457 2012
• American Journal of Lifestyle Medicine
  Gillespie Nicole, Lenz Thomas L., Resveratrol: Potential Benefits on Aging and Heart Disease
  6:5, p. 390 - 392 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., A Pharmacological/Physiological Comparison between ADHD Medications and Exercise
  6:4, p. 306 - 308 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Lessening Chemotherapy Side Effects with Lifestyle Medicine
  6:3, p. 219 - 221 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Implementing Lifestyle Medicine Guidelines into Pharmacy Practice
  6:2, p. 116 - 118 2012
• Innovations in Pharmacy
  Gillespie Nicole, Lenz Thomas L., Development and implementation of a novel lifestyle medicine advanced pharmacy practice experience.
  3:1, p. Article 64 (1 - 5) 2012
• Innovations in Pharmacy
  Lenz Thomas L., Gillespie Nicole, Faulkner Michele A., Qi Yongyue, Skradski Jessica J., Skrabal Maryann Z., Larson Jessica C., Lifestyle medicine related cardiovascular risk factor changes in employes participating in a pharmacist-run risk reduction program.
  3:4, p. Article 93 (1 - 8). 2012
• Pharmacotherapy
  Gillespie Nicole, Lenz Thomas L., Monaghan Michael S., Identifying employees with undiagnosed diabetes for participation in a pharmacist-run worksite wellness program.
  32:10, p. E260 - E261 2012
• Innovations in Pharmacy
  Lenz Thomas L., Coleman Abby W., Skradski Jessica J., Faulkner Michele A., Gillespie Nicole, Skrabal Maryann Z., Qi Yongyue, Health-related quality of life impact in employees participating in a pharmacist-run risk reduction program.
  3:4, p. Article 94 (1 - 8) 2012
• Innovations in pharmacy
  McKenzie Mallory C., Skradski Jessica J., Lenz Thomas L., Gillespie Nicole D., Medication Adherence Improvements in Employees Participating in a Pharmacist-Run Risk Reduction Program
  3:4 2012
• American Journal of Lifestyle Medicine
  Gillespie Nicole D., Lenz Thomas L., Reducing Inflammation
  6:1, p. 21 - 23 2012
• International Journal of Pharmacy and Intergrated Life Sciences.
  Lenz TL, Johnson KL, White Nicole D., Coleman AW, Blood pressure outcomes from a pharmacist-run lifestyle medicine program in an employee health setting., p. 8 - 17 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Herbal Supplements for Stress
  5:6, p. 497 - 499 2011
• American Journal of Lifestyle Medicine
  Walter Andrea N., Lenz Thomas L., Hydration and Medication Use
  5:4, p. 332 - 335 2011
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Using Behavior Change Questionnaires to Tailor Personalized Health Communications in Pharmacy Practice
  5:2, p. 130 - 132 2011
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Myopathy in Children Receiving Chronic Corticosteroid Therapy for Asthma
  5:1, p. 44 - 46 2011
• Sports Medicine
  Lenz Thomas L., Gillespie Nicole, Transdermal patch drug delivery interactions with exercise
  41:3, p. 177 - 183 2011
• Advances in preventive medicine
  Gillespie Nicole D., Lenz Thomas L., Implementation of a Tool to Modify Behavior in a Chronic Disease Management Program
  2011, p. 215842 - 5 2011
• Journal of the American Pharmacists Association
  Lenz Thomas L., Monaghan Michael S., Implementing lifestyle medicine with medication therapy management services to improve patient-centered health care
  51:2, p. 184 - 188 2011
• Journal of the American Pharmacists Association
  Lenz Thomas L., Monaghan Michael S., Pay-for-performance model of medication therapy management in pharmacy practice
  51:3, p. 425 - 431 2011
• Journal of Obesity
  Egras Amy M., Hamilton William R., Lenz Thomas L., Monaghan Michael S., An evidence-based review of fat modifying supplemental weight loss products
  2011 2011
• Expert opinion on drug metabolism & toxicology
  Lenz Thomas L., The effects of high physical activity on pharmacokinetic drug interactions
  7:3, p. 257 - 266 2011
• Wilson Amy F., Lenz Thomas L., Monaghan Michael S., Making your pharmacy practice department 'in-dispense-able' 2011
• American journal of pharmaceutical education
  Foral Pamela A., Monaghan Michael S., Walters Ryan W., Merkel Jennifer J., Lipschultz Jeremy H., Lenz Thomas L., Turner Paul D., Faculty and student expectations and perceptions of e-mail communication in a campus and distance doctor of pharmacy program.
  74:10, p. 191 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Combining Lifestyle Medicine With Medication Therapy Management Services in a Community Pharmacy Setting
  4:6, p. 484 - 487 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Medication Adherence and Its Connection With Depression and Lifestyle Medicine
  4:5, p. 413 - 415 2010
• Innovations in pharmacy
  Lenz Thomas L., Skradski Jessica, Skrabal Maryann Z., Ferguson Liz, Monaghan Michael S., A Lifestyle Medicine Clinic in a Community Pharmacy Setting
  1:1 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., The Ambulatist
  4:2, p. 134 - 137 2010
• American Journal of Pharmaceutical Education
  Packard Kathleen A., Destache Christopher J., Lenz Thomas L., A tool to teach heart failure treatment guidelines and to assess heart failure therapy in a pharmacy cardiology rotation
  74:6, p. 1 - 7 2010
• American journal of pharmaceutical education
  Packard Kathleen A., Lenz Thomas L., Destache Christopher J., Teaching heart failure treatment guidelines and assessing heart failure therapy
  74:6, p. 1 - 7 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Leucine With Resistance Training for the Treatment of Sarcopenia
  4:4, p. 317 - 319 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Pharmacokinetic Drug Interactions With Physical Activity
  4:3, p. 226 - 229 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Pharmacodynamic Interactions with Exercise and Beta-Blocker Medications
  3:6, p. 454 - 457 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Are Physically Active Individuals Taking Statins at Increased Risk for Myopathy?
  3:4, p. 287 - 289 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Minorities and Disease Prevention in Pharmacy Practice
  3:3, p. 198 - 200 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Vitamin D Supplementation and Cancer Prevention
  3:5, p. 365 - 368 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Effects of Food on the Most Commonly Used Medications in School-Age Children
  3:2, p. 119 - 122 2009
• Journal of Multidisciplinary Healthcare
  Sexson Emily L., Haddad Ann Ryan, Monaghan Michael S., Lenz Thomas L., Jensen Gail, Elsasser Gary, Use of a multidisciplinary tool to achieve target outcomes in native American patients with diabetes
  1, p. 73 - 77 2008
• Journal of the American Pharmacists Association
  Lenz Thomas L., Monaghan Michael S., Lifestyle modifications for patients with hypertension
  48:4, p. e92 - 9; quiz e100 2008
• Preventing Chronic Disease
  Lenz Thomas L., Hetterman Elizabeth A., Monaghan Michael S., Therapeutic lifestyle strategies taught in U.S. pharmacy schools
  4:4 2007
• American journal of pharmaceutical education
  Lenz Thomas L., An elective course on lifestyle modifications in pharmacotherapy
  71:5 2007
• Journal of Interprofessional Care
  Lenz Thomas L., Monaghan Michael S., Ekeler Janet L., Hayes Mary M., An interprofessional medication risk assessment program
  20:5, p. 558 - 560 2006
• Journal of Pharmacy Teaching
  Lenz Thomas L., Faulkner Michele A., Monaghan Michael S., Assessing the use of two-way interactive video (TWIV) conferencing to offer heart failure continuing education to rural pharmacists
  13:1, p. 29 - 36 2006
• Journal of Pharmacy Teaching
  Lenz Thomas L., Instructor workload of a campus-based versus a web-based pharmacy course
  12:2, p. 97 - 106 2006
• International journal of chronic obstructive pulmonary disease
  Faulkner Michele A., Lenz Tom L., Stading Julie A., Cost-effectiveness of smoking cessation and the implications for COPD.
  1:3, p. 279 - 287 2006
• American journal of pharmaceutical education
  Lenz Thomas L., Monaghan Michael S., Wilson Amy F., Tilleman Jennifer A., Jones Rhonda M., Hayes Mary M., Using performance-based assessments to evaluate parity between a campus and distance education pathway
  70:4, p. 1 - 6 2006
• HeartDrug
  Lenz Thomas L., Hilleman Daniel E., Nesiritide usage in decompensated heart failure
  5:2, p. 81 - 88 2005
• Consultant Pharmacist
  Faulkner Michele A., Ryan-Haddad Ann M., Lenz Thomas L., Degner Kayleen, Osteoporosis in long-term care residents with multiple sclerosis
  20:2, p. 128 - 136 2005
• Expert Review of Pharmacoeconomics and Outcomes Research
  Hunter Claire B., Ndemo Francis, Lenz Thomas L., Maciejewski Stephanie, Hilleman Daniel E., Nesiritide for heart failure
  5:1, p. 15 - 21 2005
• Journal of the American Pharmacists Association
  Lenz Thomas L., Stading Julie A., Lifestyle modification counseling of patients with dyslipidemias by pharmacists and other health professionals
  45:6, p. 709 - 713 2005
• Journal of the American Pharmacists Association
  Lenz Thomas L., Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemias in adults
  45:4, p. 492 - 502 2005
• American journal of pharmaceutical education
  Lenz Thomas L., Jones Rhonda M., Monaghan Michael S., Faculty workload comparison between a campus-based and internet-based patient assessment course
  69:4, p. 495 - 499 2005
• American Heart Journal
  Mooss Aryan N., Hilleman Daniel E., Lenz Thomas L., Rovang Karen S., Arcidi Joseph M., Mohiuddin Syed M., Packard Kathleen A., Wurdeman Richard L., Sugimoto Jeffrey T., Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: The Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial
  148:4, p. 641 - 648 2004
• Pharmacotherapy
  Lenz Thomas L., Foral Pamela A., Malesker Mark A., Hunter Claire B., Hilleman Daniel E., Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failure
  24:9, p. 1137 - 1146 2004
• Journal of the American Pharmacists Association
  Lenz Thomas L., Hamilton William R., Supplemental products used for weight loss
  44:1, p. 59 - 68 2004
• Sports Medicine
  Lenz Thomas L., Lenz Nancy J., Faulkner Michele A., Potential interactions between exercise and drug therapy
  34:5, p. 293 - 306 2004
• Advances in Pharmacy
  Lenz Thomas L., Faulkner Michele A., Ryan-Haddad Ann M., Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemia
  2, p. 136 - 145 2004
• Journal of cardiac failure
  Lenz Thomas L., Foral Pamela A., Malesker Mark A., Wadibia Chuma E., Lucas Daniel B., Hunter Claire B., Hilleman Daniel E., Impact of nesiritide on complications and health-care resources in decompensated heart failure
  9:5, p. S66 - S66 2003
• Annals of Pharmacotherapy
  Faulkner Michele A., Lenz Thomas L., Dalmady-Israel Christina, Edouard Bruno, Bertoni John M., Gabapentin for the treatment of tremor
  37:2, p. 282 - 286 2003
• Clinical Pharmacokinetics
  Lenz Thomas L., Wilson Amy F., Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke
  42:10, p. 909 - 920 2003
• Pharmacotherapy
  Packard Kathleen A., Hilleman Daniel E., Backes James M., Lenz Thomas L., Wurdeman Richard L., Destache Christopher J., Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease
  22:12 I, p. 1527 - 1532 2002
• Chest
  Wurdeman Richard L., Mooss Aryan N., Mohiuddin Syed M., Lenz Thomas L., Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery
  121:4, p. 1203 - 1210 2002
• ASHP Midyear Clinical Meeting
  Hilleman Daniel E., Packard Kathleen A., Lenz Thomas L., Wurdeman Richard L., Destache Christopher J., Comparison of gemfibrozil and fenofibrate in hyperlipidemic coronary heart disease patients
  36, p. P - E 2001
• American journal of hypertension
  Hilleman Daniel E., Wurdeman Richard L., Lenz Thomas L., P-250: Cost-effectiveness evaluation of fixed-dose combination of angiotensin-II receptor blockers with and without hydrochlorothiazide
  14:S1, p. 112A - 113A 2001
• Pharmacotherapy
  Hilleman Daniel E., Wurdeman Richard L., Lenz Thomas L., Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease
  21:4, p. 410 - 415 2001
• Pharmacotherapy
  Lenz T. L., Wurdeman R. L., Hilleman D. E., Comparison of 24-hour blood pressure profiles in patients with hypertension who were switched from amlodipine to nisoldipine
  21:8, p. 898 - 903 2001
• P and T
  Lenz T. L., Hilleman D. E., The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease
  26:11, p. 561 - 562+565 2001
• Drugs of Today
  Lenz T. L., Hilleman D. E., Dofetilide
  36:11, p. 759 - 771 2000
• Chest
  Wurdeman Richard L, Mooss Aryan N, Lenz Thomas L, Hilleman Daniel E, Ryschon Kay, COMPARATIVE ANTIARRHYTHMIC EFFECTS OF PROPHYLACTIC AMIODARONE VERSUS SOTALOL BY META-ANALYSIS FOLLOWING CARDIAC SURGERY
  118:4, p. 108 2000
• Annals of Pharmacotherapy
  Lenz Thomas L., Hilleman Daniel E., Aggrenox
  34:11, p. 1283 - 1290 2000
• Pharmacotherapy
  Lenz Thomas L., Hilleman Daniel E., Dofetilide, a new class III antiarrhythmic agent
  20:7 I, p. 776 - 786 2000
• Chest
  Scott Walter J, Hilleman D E, Lenz T L, SMOKING CESSATION TREATMENT STRATEGIES FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY
  116:4, p. 286 1999
• Chest
  Hilleman Daniel E, Wurdeman R L, Lenz T L, RATE CONTROL IN POST-CABG ATRIAL FIBRILLATION: A COMPARISON OF BETA-BLOCKER VERSUS CALCIUM ANTAGONIST WITH AND WITHOUT DIGOXIN
  116:4, p. 282 1999

Presentations

• Dr. Tom Lenz: Panel Discussion. Sustainable Strategies to Support Well-Being for Healthcare Professionals. Presented at the Midwest Chapter of the American College of Healthcare Executives. April 24, 2024. Omaha, NE 2024
• Dr. Tom Lenz: HW Application in Chronic Disease. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference 2024
• Dr. Tom Lenz: Connection, Compassion, Contemplation: Guiding Principles Toward Well-Being and Improved Mental Health. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference. (invited) 2024
• Dr. Tom Lenz: Chronic Stress as a Pathway to Chronic Disease. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference. 2024
• Dr. Tom Lenz: Sleep as Medicine. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference 2024
• Dr. Tom Lenz: What is Integrative Health and Wellness? Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference 2024
• 2023
• Dr. Tom Lenz pesented: Connection, Compassion, Contemplation. Guiding Principles Toward Well-Being. Presented at Leadership Retreat for CHI/Mercy Hospital. April 26, 2023. Council Bluffs, Iowa. (Invited) 2023
• Dr. Tom Lenz pesented: Connection, Compassion, Contemplation. Guiding Principles Toward Well-Being. Presented at Leadership Retreat for CHI/Immanuel Medical Center. April 14, 2023. Omaha, Nebraska. (Invited) 2023
• Lifestyle Medicine. Presented to the faculty and students in the School of Pharmacy and Health Professions at Creighton University. March 25, 2014. (invited) 2014
• Creating a Personal Teaching Philosophy Statement. Department of Pharmacy Practice, Creighton University. December 18, 2013. Omaha, Nebraska 2013
• Be Your Own First Patient. Presented at the Nebraska Department of Health and Human Services Conference on Creating a Culture of Wellness in Healthcare Settings. May 18, 2013. Nebraska City, NE. (invited) (presented with Nicole White, PharmD) 2013
• Lifestyle Medicine in Pain Management. Presented at: TOGETHER. Providing Quality Care to Pain Patients in Iowa. A Multidisciplinary Conference. February 8, 2013. Des Moines, Iowa. (Invited) 2013
• Cardiovascular and Diabetes Risk Reduction Program Outcomes. Presented to the Creighton University Wellness Council. November 8, 2012. Omaha, Nebraska. (Invited) 2012
• Optimizing Your Pharmacy Distance Pathway Educational Mentor. Presented to the Creighton University Pharmacy Program Faculty. October 23, 2012. Omaha, Nebraska. 2012
• The Ambulatist: A Novel Employee Health Specialty Position. American College of Preventive Medicine 2012 Annual Meeting. February 23, 2012. Orlando, FL 2012
• Implementing Lifestyle Medicine with Clinical Pharmacy Practice. Presented to the Midwest College of Clinical Pharmacy. November 29, 2011. Omaha, Nebraska. (Invited) 2011

Awards

• Nomination - S.J. Diversity Award for Excellence & Innovation
  2015 John P. Schlegel, S.J. Diversity Award for Excellence & Innovation
• Certificate of Recognition
  Strategic Plan Initiatives, Creighton University
• Excellence in Innovation
  Nebraska Pharmacists Association

Consulting

• Faculty Associate - Office of Interprofessional Scholarship, Service, and Education, Creighton University School of Pharmacy and Health Professions
  2006 - 2006
• Consultant - Creighton University Athletic Department
  2000 - 2000